Cells 12 , 1234 (2023)
doi:10.1021/jf010321
Supporting these findings, a recent PET (positron emission tomography) imaging study by (Kato et al., 2023) demonstrated a significant reduction in Complex I availability in the anterior cingulate cortex of ASD individuals, reinforcing the hypothesis that compromised mitochondrial respiration plays a key role in ASD pathophysiology
[...] To view or add a comment, sign in Eli Lilly's VERVE-102, an investigational single-dose gene-editing medicine, shows groundbreaking potential as a one-time treatment for hypercholesterolemia by durably reducing LDL cholesterol by up to 62% and PCSK9 by up to 88% in the Phase 1b Heart-2 trial
Success depends heavily on establishing non-medication-based habitsexercise consistency, protein intake, sleep quality, and stress managementbefore discontinuing therapy
Liraglutide therapy exhibited good safety tolerability, with gastrointestinal symptoms representing the predominant adverse events: nausea affected 46% of liraglutide users vs
